Catumaxomab vs Erlotinib

## Catumaxomab vs Erlotinib: Overview

This comparison examines the pharmacological differences between **Catumaxomab** and **Erlotinib**.

## Mechanism of Action

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Catumaxomab — N/A; Erlotinib — 36 hours.

## Chemical Properties

**Molecular Formula**: Catumaxomab — N/A; Erlotinib — C22H23N3O4.

**Molecular Weight**: Catumaxomab — N/A; Erlotinib — 393.4380 g/mol.

**Type**: Catumaxomab — Antibody; Erlotinib — Small molecule.